In the upcoming webcast, Investing for tomorrow, at the moment: Exploring the way forward for well being care, Steve Jones, Shopper Portfolio Supervisor, Principal World Systematic Options; Jeffrey Schwarte, Portfolio Supervisor and Head of Systematic Options, Principal World Systematic Options; and Matthew Cohen, Head of ETF Specialist Group, Principal World Buyers, will spotlight the healthcare and know-how funding themes and their place in your portfolios.
Particularly, the Principal Healthcare Innovators Index ETF (Nasdaq: BTEC) can present a focused funding technique designed to capitalize on innovation within the healthcare sector.
With its positioning on the cusp of healthcare innovation, a theme being spotlighted by the COVID-19 pandemic, BTEC is proving youthful healthcare investments that may be served. BTEC seeks to faucet into the rising demand for healthcare options as demographic developments have pushed healthcare spending to greater than double within the final 20 years, in accordance with Principal.
BTEC tracks the Nasdaq U.S. Healthcare Innovators Index, which is designed to supply publicity to early-stage small-capitalization healthcare firms. These are primarily biotechnology and life science, which have the potential to create cures for most cancers, develop new medical applied sciences, or spearhead different medical advances.
Moreover, the ETF offers entry to specialised healthcare options, bringing an environment friendly, systematic method to figuring out and deciding on smaller healthcare firms that many buyers neglect.
Because the coronavirus outbreak, well being care know-how has come to the fore, with varied improvements receiving focus as a way to fight the virus. Related developments proceed to learn BTEC, preserving the fund away from debates resembling insurance coverage and prescription drugs pricing.
Monetary advisors who’re occupied with studying extra about the way forward for well being care can register for the Thursday, April 29 webcast right here.
Learn extra on ETFtrends.com.
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially mirror these of Nasdaq, Inc.